The effect of reduced RDI of chemotherapy on the outcome of breast cancer patients

The aims of this study were to investigate the impact of the relative dose intensity (RDI) of chemotherapy on disease-free survival (DFS) and overall survival (OS), to identify the optimal RDI cut-off points with the docetaxel, epirubicin and cyclophosphamide (TEC) regimen for stage I–III breast can...

Descripción completa

Detalles Bibliográficos
Autores principales: Qi, Wanwan, Wang, Xiaoyi, Gan, Lu, Li, Yunhai, Li, Hongyuan, Cheng, Qiao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7413525/
https://www.ncbi.nlm.nih.gov/pubmed/32764734
http://dx.doi.org/10.1038/s41598-020-70187-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7413525/
https://www.ncbi.nlm.nih.gov/pubmed/32764734
http://dx.doi.org/10.1038/s41598-020-70187-8

Ejemplares similares